Salmon SE - Search Results

1

Antiproliferative and antitumor activity of the 2-cyanoaziridine compound imexon on tumor cell lines and fresh tumor cells in vitro.

Hersh EM, Gschwind CR, Taylor CW, Dorr RT, Taetle R, Salmon SE. Hersh EM, et al. Among authors: salmon se. J Natl Cancer Inst. 1992 Aug 19;84(16):1238-44. doi: 10.1093/jnci/84.16.1238. J Natl Cancer Inst. 1992. PMID: 1640482

2

In vitro cytotoxicity against fresh human tumors and P388 leukemia predicts the differential in vivo activity of a series of anthracene anticancer drugs.

Alberts DS, Dorr RT, Wunz TP, Remers WA, Einspahr J, Liu R, Salmon SE. Alberts DS, et al. Among authors: salmon se. Anticancer Drugs. 1991 Feb;2(1):69-77. doi: 10.1097/00001813-199102000-00010. Anticancer Drugs. 1991. PMID: 1958855

3

Effects of interleukin-4 on the in vitro growth of human lymphoid and plasma cell neoplasms.

Taylor CW, Grogan TM, Salmon SE. Taylor CW, et al. Among authors: salmon se. Blood. 1990 Mar 1;75(5):1114-8. Blood. 1990. PMID: 2306518 Free article.

4

Sensitivity of multiple myeloma to imexon in the human tumor cloning assay.

Salmon SE, Hersh EM. Salmon SE, et al. J Natl Cancer Inst. 1994 Feb 2;86(3):228-30. doi: 10.1093/jnci/86.3.228. J Natl Cancer Inst. 1994. PMID: 8283495 No abstract available.

5

Novel antitumor 2-cyanoaziridine-1-carboxamides.

Iyengar BS, Dorr RT, Alberts DS, Hersh EM, Salmon SE, Remers WA. Iyengar BS, et al. Among authors: salmon se. J Med Chem. 1999 Feb 11;42(3):510-4. doi: 10.1021/jm980600x. J Med Chem. 1999. PMID: 9986721

6

Effects of suramin on in vitro growth of fresh human tumors.

Taylor CW, Lui R, Fanta P, Salmon SE. Taylor CW, et al. Among authors: salmon se. J Natl Cancer Inst. 1992 Apr 1;84(7):489-94. doi: 10.1093/jnci/84.7.489. J Natl Cancer Inst. 1992. PMID: 1545438

7

Cytostatic and cytotoxic activity of lymphokine-activated killer cell supernatants.

Hersh EM, Scuderi P, Grimes WJ, Chong A, Brailey JL, Gschwind CR, Salmon SE. Hersh EM, et al. Among authors: salmon se. Cancer Immunol Immunother. 1989;30(1):65-70. doi: 10.1007/BF01665032. Cancer Immunol Immunother. 1989. PMID: 2480843 Free PMC article.

8

Increased peripheral blood leukocyte cytotoxic activity in cancer patients during the continuous intravenous administration of recombinant human tumor necrosis factor.

Charnetsky PS, Greisman RA, Salmon SE, Hersh EM, Scuderi P. Charnetsky PS, et al. Among authors: salmon se. J Clin Immunol. 1989 Jan;9(1):34-8. doi: 10.1007/BF00917125. J Clin Immunol. 1989. PMID: 2784796

9

A phase I study of therapy with recombinant granulocyte-macrophage colony-stimulating factor administered by IV bolus or continuous infusion.

Rifkin RM, Hersh EM, Salmon SE. Rifkin RM, et al. Among authors: salmon se. Behring Inst Mitt. 1988 Aug;(83):125-33. Behring Inst Mitt. 1988. PMID: 3071327

10

Antitumor activity of combretastatin-A4 phosphate, a natural product tubulin inhibitor.

Dorr RT, Dvorakova K, Snead K, Alberts DS, Salmon SE, Pettit GR. Dorr RT, et al. Among authors: salmon se. Invest New Drugs. 1996;14(2):131-7. doi: 10.1007/BF00210783. Invest New Drugs. 1996. PMID: 8913833

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

288 results

Search Page

Filters